AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeOne Medicines Ltd. Director's Dealing 2018

Feb 13, 2018

30073_dirs_2018-02-13_ee9a8681-99e9-48f5-9575-89898f40f12a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2017-03-16

Reporting Person: OYLER JOHN (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	24853455	Direct

Footnotes

F1: The total reported in Column 5 has been adjusted to correct an error in the total holding first reflected on the Form 4 filed on March 20, 2017 and the subsequent Form 4s.